Equities

Shanghai HeartCare Medical Technology Corp Ltd

Shanghai HeartCare Medical Technology Corp Ltd

Actions
Health CareMedical Equipment and Services
  • Price (HKD)19.22
  • Today's Change0.00 / 0.00%
  • Shares traded3.60k
  • 1 Year change-53.24%
  • Beta--
Data delayed at least 15 minutes, as of May 14 2024 08:32 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Shanghai HeartCare Medical Technology Corp Ltd is a China-based company engaged in the research and development of innovative neuro-interventional medical device. The Company's product portfolio includes both neuro-interventional and cardiac medical devices, and its main products are CaptorTM thrombectomy device (Captor) and left atrial appendage occluder. The Company's product portfolio extends from the treatment and prevention of ischemic stroke, including acute ischemic stroke and intracranial stenosis to the treatment of hemorrhagic stroke. The Company's other products include the balloon guiding catheter, the ExtraFlex distal access catheter and SupSelek microcatheter. The Company distributes its products within the domestic market.

  • Revenue in HKD (TTM)250.95m
  • Net income in HKD-101.54m
  • Incorporated2016
  • Employees368.00
  • Location
    Shanghai HeartCare Medical Technology Corp Ltd1F and 3F, Building 38No. 356, Zhengbo Road, Lingang New AreaPilot Free Trade ZoneSHANGHAI 201201ChinaCHN
  • Phone+86 2 158975055
  • Websitehttp://www.heartcare.com.cn/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Sun Hing Vision Group Holdings Ltd682.76m-31.66m176.06m3.20k--0.2519--0.2579-0.1205-0.12052.602.660.70265.763.73206,897.00-3.26-1.96-4.29-2.5415.5718.63-4.64-2.392.18-4.980.0767---19.60-6.79-436.13---38.96--
Kelfred Holdings Ltd393.28m1.39m210.00m1.01k151.081.1517.830.5340.00280.00280.78660.36641.524.613.84389,004.900.53810.29570.7240.435814.4917.360.35290.19472.022.510.0767---15.50-1.36-84.89-46.07----
Vincent Medical Holdings Ltd717.97m57.28m261.33m1.26k4.510.48232.700.3640.08870.08871.110.82940.94892.753.96568,016.607.699.6011.0013.9833.4834.938.119.521.69--0.064438.3114.108.03429.2013.1024.4211.44
Elife Holdings Ltd177.84m-15.57m299.50m63.00--2.28--1.68-0.0202-0.02020.22530.11611.8764.3011.324,041,909.00-19.54-46.05-17.05-43.714.112.86-10.45-44.181.40--0.1211--56.519.3143.00---70.90--
Arts Optical International Holdings Ltd1.20bn51.32m316.74m3.70k6.170.58453.450.26480.13290.13293.101.401.015.303.20323,326.804.79-7.5110.18-13.8931.0125.184.74-8.380.921973.320.0383--4.560.005-55.28--21.11--
Rainmed Medical Ltd79.08m-125.10m321.14m354.00--0.5773--4.06-0.1071-0.10710.06770.47640.11592.8438.14223,394.10-18.53---20.37--66.31---159.88--8.77--0.037---12.42--91.39------
Broncus Holding Corp80.11m-219.44m321.59m308.00--0.2221--4.01-0.4492-0.44920.1642.750.04910.67241.11260,094.10-13.45---14.00--70.47---273.93--18.34--0.0125--8.95---0.1962------
Austar Lifesciences Ltd1.90bn-35.22m415.19m1.61k--0.497335.560.218-0.0687-0.23913.721.630.77573.901.801,183,200.00-1.534.39-3.449.9819.0523.09-1.974.561.13-1.660.3902---18.2316.65-131.28------
China Health Group Ltd74.43m-29.50m469.41m133.00--6.23--6.31-0.0651-0.06510.16410.15720.25363.823.03543,313.90-9.74-10.57-17.56-21.4233.6233.05-38.40-32.700.9156-4.910.0765---28.6025.81-244.50--50.63--
Shanghai Bio-heart Biologicl Tech Co Ltd0.00-189.98m487.87m32.00--0.6036-----0.7796-0.77960.003.310.00----0.00-20.99---22.30----------20.16--0.0023------13.88------
Ziyuanyuan Holdings Group Ltd537.83m15.73m662.20m184.0039.161.8321.771.230.03930.03931.340.84370.81844.543.022,922,964.002.282.613.673.7124.69--2.786.131.752.340.313--53.4152.48-7.90-2.9897.56--
Shanghai HeartCare Medcl Tech Corp Ltd250.95m-101.54m746.40m368.00--0.6425--2.97-2.67-2.676.5929.920.18490.49314.54681,922.10-7.48---7.88--70.48---40.46--14.37--0.0327--26.94--53.08------
Guanze Medical Infrm Indstry (Hldng) Ltd168.57m29.77m902.50m56.0030.313.1024.635.350.03130.03130.17740.30630.48765.371.183,010,150.008.72--10.54--54.72--17.89--6.2552.600.0748---11.88--53.63------
Data as of May 14 2024. Currency figures normalised to Shanghai HeartCare Medical Technology Corp Ltd's reporting currency: Hong Kong Dollar HKD

Institutional shareholders

5.61%Per cent of shares held by top holders
HolderShares% Held
Temasek Holdings Pte Ltd. (Investment Management)as of 30 Jun 20231.77m5.60%
HuaAn Fund Management Co., Ltd.as of 30 Jun 20233.05k0.01%
Data from 31 Dec 2023 - 31 Dec 2023Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.